SEC Form 4 · accession 0001493152-17-010200
ONCOSEC MEDICAL Inc · ONCS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Annalisa Jenkins
Director
Period of report
Sep 5, 2017
Accepted (ET)
Sep 5, 2017 · 6:18 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001444307
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $0.979 | Sep 5, 2017 | A | 100,000 | A | — | Sep 5, 2027 | Common Stock | 100,000 | 100,000 | D |
Explanation of responses
- F1Vesting in 12 equal monthly increments, with the first 1/12th vesting on the first monthly anniversary of the Grant Date pursuant to the OncoSec Medical Incorporated 2011 Stock Incentive Plan.